Please assess the completion status of the following clinical trial:

Trial Title: Low Dose hCG in the Late Follicular Phase

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* \< 36 years on day of randomisation~* FSH \< 12 in the early follicular phase~* Normal ultrasound scan~* BMI between 18 and 29 (both inclusive)~* Randomisation at outpatient clinic~Exclusion Criteria:~* Endometriosis ≥ grade 3~* PCO syndrome~* Poor responder~* Endocrine or metabolic abnormalities

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 36 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): Patients undergo a standard antagonist protocol for in-vitro fertilisation, and are stimulated with recombinant gonadotropins.
- B (Type: EXPERIMENTAL): Patients are undergo an antagonist protocol for in-vitro fertilisation and are stimulated with recombinant gonadotropins. When the patient has an estradiol value of 600 ng/L or more and when the patient has at least 6 follicles of 12 mm, the administration of gonadotropins is stopped and replaced by low dose human chorionic gonadotropins.

Based on this trial design, predict the completion outcome and termination type (if applicable).